FindTrial
Sign In

Feasibility study of Risk Reducing Mastectomy and Risk Reducing Salpingo-Oophorectomy for Hereditary Breast and Ovarian Cancer

Feasibility study of Risk Reducing Mastectomy and Risk Reducing Salpingo-Oophorectomy for Hereditary Breast and Ovarian Cancer - Feasibility study of RRM and RRSO for HBOC

Status
Recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000028849
Enrollment
10
Registered
2017-10-01
Start date
2017-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HBOC

Interventions

None listed

Sponsors

Kitasato University
Lead Sponsor
Kitasato University Hospital, Gynecology Kitasato University Hospital, Breast and Endocrine Surgery
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Genetic testing has confirmed a mutation in BRCA 1/2, and the individual desires RRM/RRSO after genetic counseling. 2) It is desirable person who have children, or understand that fertility is lost after this treatment with Husband, or does not wish to have baby, or have willing RRSO priority than wish to have baby. 3) Fully understanding the symptoms after RRM/RRSO. 4) Fully understanding that RRM/RRSO is self-pay. 5) Fully understanding that RRM/RRSO is clinical trial. 6) The person who choose RRM/RRSO does not have malignacy of breast and ovary.

Exclusion criteria

Exclusion criteria: doctor's decision not to be registered to this study

Design outcomes

Primary

MeasureTime frame
1Safety of surgery 2Prognosis 3QOL after surgery 4Complication of surgery 5Pathological data—

Countries

Japan

Contacts

Public ContactNaomi Araki

Kitasato University Hospital Genetics

arnaoe@kitasato-u.ac.jp042-778-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026